Back

AFT Pharmaceuticals launches Combogesic in U.S., expanding availability to 66 countries

Verifying
  • AFT Pharmaceuticals launched FDA-approved Combogesic in the United States for adult acute-pain treatment.
  • Combogesic combines prescription-strength acetaminophen and ibuprofen in one tablet for short-term use.
  • The launch brings Combogesic availability to 66 countries, according to AFT Pharmaceuticals.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.